Avandia Roundup

• Our neighbors summarize.  So do our other neighbors.
• In The Pipeline comments.
• DrugWonks cheers, and cheers, and discusses.
• A new-to-me blog, but one I’m liking more just about every day, Life Sciences Daily, discusses and goes after DrugWonks.  In so doing, Ogan Gurel identifies for me what it is that sometimes bugs me about DrugWonks, and it’s similar to what sometimes bugs me about a lot of the sites funded by particular groups or industries (not at all limited to DrugWonks – just a convenient example) — they often don’t act like adults, instead seeming more like teenagers arguing over the best Scary Movie sequel.

–BC

(Usual disclosure: I do a small amount of work for pharma clients.  GSK is not, nor has it ever been, a client.)